Honing the Priorities and Making the Investment Case for Global Health

PLoS Biology

Volumn 14, Issue 3, 2016, Pages

  Mundel, Trevor ^a  

^a BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXPECTATION; HEALTH; INVESTMENT; THINKING; ECONOMICS; GLOBAL HEALTH; HEALTH CARE PLANNING;

GLOBAL HEALTH; HEALTH PRIORITIES;

EID: 84962176756     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1002376     Document Type: Article

References (17)

1. Kalra S, Kelkar D, Galwankar SC, et al. The Emergence of Ebola as a Global Health Security Threat: From “Lessons Learned” to Coordinated Multilateral Containment Efforts. Journal of Global Infectious Diseases. 2014;6(4):164–177. doi: 10.4103/0974-777X.14524725538455
2. 2014 Ebola Outbreak in West Africa–Case Counts. World Health Organization. http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html. Accessed: 13 December 2015.
3. The economic impact of the 2014 Ebola epidemic: short and medium term estimates for Guinea, Liberia and Sierra Leone. The World Bank. http://documents.worldbank.org/curated/en/2014/09/20214465/economic-impact-2014-ebola-epidemic-short-medium-term-estimates-guinea-liberia-sierra-leone. Accessed 16 December 2015
4. Ebola response funding. World Health Organization. http://www.who.int/csr/disease/ebola/funding/en/. Accessed: 15 December 2015.
5. Ebola research and development landscape of clinical candidates and trials. Public report October, 2015 http://www.who.int/medicines/ebola-treatment/rd_clinical_candidates_trials_report/en/. Accessed: 16 December 2015.
6. Schwalbe N, The Global Alliance for Vaccines and Immunization (GAVI). Vaccine. 20November2012. 30Suppl 4:x. doi: 10.1016/S0264-410X(12)01438-723510771
7. Every Child Counts: The Vaccine Alliance Progress Report 2014. http://www.gavi.org/Library/Publications/GAVI-Progress-reports/Gavi-Progress-Report-2014/. Accessed: 15 December 2015.
8. Hundreds of Millions More Children to Receive Protection against Deadly Diseases, a Chance at a Healthy Future. 27 January 2015. http://www.gatesfoundation.org/Media-Center/Press-Releases/2015/01/GAVI-Replenishment-Conference
9. Dheda K., et al. Tuberculosis. The Lancet. 13September2015. doi: 10.1016/S0140-6736(15)00151-8
10. Nathan C, Cooperative development of antimicrobials: looking back to look ahead (2015). Nature Reviews Microbiology. Volume 13, 651–657. doi: 10.1038/nrmicro352326373373
11. Summers et al., Economists’ declaration on universal coverage. The Lancet. Volume 386, Issue 10008, 2112–2113. doi: 10.1016/S0140-6736(15)00242-1
12. Simon Tripp and Martin Grueber, Economic impact of the human genome project. Battelle, the Business of Innovation (2011). http://www.battelle.org/docs/default-document-library/economic_impact_of_the_human_genome_project.pdf?sfvrsn=2. Accessed 16 December 2015.
13. Evans et al., Portfolio analysis and R&D decision making. Nature Reviews Drug Discovery (2009). Volume 8, 189–190. doi: 10.1038/nrd274419182818
14. Bhatt S, et al., The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature (2015). Volume 000: 1–9.
15. Korschun, H. Gates Foundation names Emory Global Health Institute lead partner in child health network. http://news.emory.edu/stories/2015/05/gates_foundation_emory_ghi_ianphi_champs_partner/campus.html.
16. Neglected Tropical Diseases. World Health Organization. http://www.who.int/neglected_diseases/diseases/en/. Accessed: 15 December 2015.
17. Roth GA, et al., Global burden of cardiovascular disease. Circulation (2015). 132:1270–1282doi: 10.1161/CIRCULATIONAHA.115.01602126408271